Çinier Göksel, Tse Gary, Baranchuk Adrian
Department of Cardiology, Kaçkar State Hospital, Rize, Turkey.
Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China; Xiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
Turk Kardiyol Dern Ars. 2020 Mar;48(2):158-166. doi: 10.5543/tkda.2020.06118.
Brugada syndrome (BrS) is a congenital channelopathy associated with the development of malignant ventricular arrhythmias and sudden cardiac death. The diagnosis of BrS is made based on Brugada ECG pattern and clinical history. Brugada phenocopies (BrP) are clinical entities that are characterized by ECG patterns identical to those of BrS but arise from different underlying conditions such as metabolic abnormalities, myocardial ischemia and mechanical compression. Distinction between the two is important because BrS requires investigations for risk stratification whereas BrP requires appropriate treatment for the underlying conditions. In the present review, we summarized the current data in the literature, systematic diagnostic approach, gaps in the literature and future perspective on BrP.
Brugada综合征(BrS)是一种与恶性室性心律失常和心源性猝死发生相关的先天性离子通道病。BrS的诊断基于Brugada心电图模式和临床病史。Brugada综合征拟表型(BrP)是一类临床病症,其特征是心电图模式与BrS相同,但由不同的潜在病因引起,如代谢异常、心肌缺血和机械压迫。区分两者很重要,因为BrS需要进行危险分层调查,而BrP需要针对潜在病因进行适当治疗。在本综述中,我们总结了文献中的现有数据、系统的诊断方法、文献中的空白以及BrP的未来展望。